- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Neuropathic pain
- Meeting Date: November 2021
- Public Summary Document (PSD) November 2021 PBAC Meeting - (PDF 331KB)
- Public Summary Document (PSD) November 2021 PBAC Meeting - (Word 34KB)
Pregabalin – November 2021
Pregabalin: Oral solution 20 mg per mL, 473 mL; Pregabalin-AFT®
Last updated
18 March 2022